Anastrozole

본문 바로가기


Home > Product > Anastrozole
Product
Anastrozole
Posting date : Dec 23, 2010
Membership
Free Member Scince Oct 29, 2009
Keyword :
Category
Contact
          0 likes     
Product Detail
Company Info
 
Quick Detail
Place of Origin
HS-CODE
30-
Package & Delivery Lead Time
Detailed Description
By name Tetramethyl-5-(1H-1, 2, 4-triazol-1ylmethyl) 1, 3-benzenediacetionitrile CAS NO. 120511-72-0 Molecular formula C15H18N2 226.32 Specification 99 percent Melting point 81-82 C Appearance white or white crystalline powder Anastrozole is a new, highly selective nonsteroidal aromatase inhibitor indicated for the endocrine treatment of postmenopausal women with advanced breast cancer. In postmenopausal women, anastrozole prevent the synthesis of estrogens and significantly reduced plasma estrogen levels, and this has been associated with tumour regression in patients with estrogen-dependent breast cancer. Absorption of anastrozole was rapid and virtually complete after oral administration. The 1 mg per day of anastrozole is highly selective and well tolerated by patients. It has a terminal half life (30-50 h) long enough to provide for once- daily dosing and this dose produces the maximum detectable estradiol suppression. In this paper, we reviewed its mechanism, pharmacokinetics and clinical use.

ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2024 ECROBOT.COM. All rights reserved.
Top